The MD-CARE Act, a piece of legislation designed to accelerate research and provide infrastructure needed for the development of new treatments to treat all nine forms of muscular dystrophy, has passed in the Senate by unanimous consent on September 18th. The Muscular Dystrophy Association (MDA), which has been a major advocate for passage of…
News
Recent Posts
- MDA Engage: National ambassador brings message of belonging, resilience
- Relentless FSHD progression is making it hard for me to find solid ground
- Approved Duchenne gene therapy may be safe for boys as young as 2
- Fixing accessibility issues at a choir concert so the show can go on
- Experimental treatment may preserve upper limb function in DMD